Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid precursor protein (APP) expression in multiple sclerosis lesions

J Gehrmann1, R B Banati, M L Cuzner

  • 1Department of Pathology, University Hospital, Zurich, Switzerland.

Glia
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of the eHealth Literacy and Use Scale (eHLUS) to measure medical app literacy.

Public health·2025
Same author

Molecular typing of enteroviruses: comparing 5'UTR, VP1 and whole genome sequencing methods.

Pathology·2022
Same author

[Pediatric ADHD: what does the otolaryngologist need to know?].

HNO·2013
Same author

The expression of growth factor receptors during nerve regeneration.

Restorative neurology and neuroscience·2011
Same author

Spinal cord microglial cells and DRG satellite cells rapidly respond to transection of the rat sciatic nerve.

Restorative neurology and neuroscience·2011
Same author

Calcitonin gene-related peptide (CGRP) in the regenerating rat sciatic nerve.

Restorative neurology and neuroscience·2011

Amyloid precursor protein (APP) is elevated in reactive glial cells and T lymphocytes during multiple sclerosis (MS) demyelination. APP detection may serve as a sensitive marker for MS disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Amyloid precursor protein (APP) is induced in reactive glial cells during central nervous system inflammation.
  • Previous studies in animal models suggest APP's role in autoimmune CNS inflammation.

Purpose of the Study:

  • To investigate APP expression in human multiple sclerosis (MS) lesions.
  • To correlate APP levels with histopathological disease progression in MS.

Main Methods:

  • Immunocytochemistry was used to analyze APP expression in MS lesions and control tissues.
  • Antibodies targeting C- or N-terminal APP epitopes were employed.
  • Histopathological evaluation included H&E, Oil Red O, and immunocytochemistry for immune cells and glial markers.

Related Experiment Videos

Main Results:

  • APP immunoreactivity was low in control tissues, primarily in blood vessels, oligodendrocytes, and neurons.
  • Actively demyelinating MS plaques showed high APP levels on T lymphocytes, macrophages, microglia, and reactive astrocytes.
  • Chronic MS lesions exhibited lower APP levels, mainly on reactive astrocytes and some macrophages/microglia.
  • Oligodendrocytes and numerous axons also showed APP immunoreactivity, particularly with anti-C-terminal antibodies.

Conclusions:

  • APP is induced on reactive glial cells and T lymphocytes during MS demyelination.
  • APP expression levels correlate with histopathological lesion development in MS.
  • APP detection is a sensitive marker for MS disease progression.